Yerevan

Yerevan is rapidly transforming into a premier life sciences ecosystem in the South Caucasus.

As the capital of Armenia, the city is best known for its burgeoning biotechnology sector, where companies like Denovo Sciences leverage artificial intelligence (AI) and computational biology to pioneer personalized medicine and drug discovery.

The pharmaceutical industry in Yerevan has shifted toward high-value precision medicine, supported by a robust network of manufacturing facilities that meet rigorous international quality standards.

Beyond drug development, Yerevan is a rising star in medtech, specifically recognized for integrating emotional AI into medical devices, as seen with the globally acclaimed Robin the Robot by Expper Technologies.

This innovation thrives within a fertile academic research environment anchored by the National Academy of Sciences and Yerevan State University, which foster cross-disciplinary breakthroughs in genomics, molecular genetics and bioinformatics.

The city’s strategic focus on digital health and biotech startups is further bolstered by a highly skilled STEM workforce and an increasingly attractive climate for clinical trials and R&D investment.

In 2026, Yerevan’s role as a global scientific node is cemented by hosting major international summits, such as COP17, highlighting its commitment to biodiversity and biotechnical sustainability.